KOSDAQ · Healthcare · ₩356B
₩16,170+0.37%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 6.5% · as of 26.10.27
Among 34 바이오 peers
Quarterly Revenue Growth
“새 약의 성과를 협력과 시험으로 확인해가는 구간이에요.”
In the company's words · 2026 2분기 filing